Profil
Jerry Cacia worked as the Global Head of Pharmaceutical Technical Development at Genentech, Inc. from 1988 to 2016.
He then served as the Head of Biologics & Drug Product Manufacturing at F.
Hoffmann-La Roche Ltd. from 2016 to 2021.
Currently, he is the Chief Technical Officer at Graphite Bio, Inc. since 2021.
Mr. Cacia completed his undergraduate degree at the University of California, Santa Cruz.
Anciens postes connus de Jerry Cacia
| Sociétés | Poste | Fin |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2023 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | - |
Formation de Jerry Cacia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
















